Reach Us +1-217-403-9671
Global Regulatory Requirements For Transdermal Drug Delivery System | 7420
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Global regulatory requirements for transdermal drug delivery system

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Ch. Teja

Posters: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.007

With the advent of new era of pharmaceutical dosage forms, transdermal drug delivery system (TDDS) established itself as an integral part of novel drug delivery systems. Transdermal patches are polymeric formulations which when applied to skin deliver the drug at a predetermined rate across dermis to achieve systemic effects and from past 30 years there were several advancements in its development process and latest technologies are available in the market. The demand for globally acceptable transdermal products heightens the imperative for harmonization of regulatory requirements to lend efficiency and cost effectiveness to the process of product development, manufacturing and expediency to global access, and where generic companies are playing a crucial role to make them affordable. Hence review process by the regulatory authorities acts a vital role for approval of generics and the process is also being very stringent in various countries such as United States, Europe, Canada, Australia, and Japan includes standard skin irritation, sensitization and adhesion studies with the patch itself in animals/humans. The production of transdermal drug delivery system medications has increased, because these sorts of systems have proved more effective in many situations at directly sending drugs into the body.
Ch. Teja is currently pursuing her 2nd year M. Pharmacy in Pharmaceutical Regulatory Affairs from JSS University, Mysore. She has done her graduation from the same college i.e. JSS College of Pharmacy, Mysore, Karnataka. She published 2 articles in reputed journals titled ?Comparative Study of In- Process and Finished Products Quality Control Tests of Indian Pharmacopoeia, British Pharmacopoeia & United States Pharmacopoeia for Capsules and Liquid Orals? and ?New Era in US Prescription Drug Labeling? Which was also published as a poster 63rd IPC. And also attended Indo-American Pharmaceutical Regulatory Symposium- 2011 and presented a poster on ?Indian Regulations on Cosmetics?.